We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
LSE:0EVI
​
​
logo

Innate Pharma S.A. (0EVI)

LSE • 0EVI • FR0010331421

1.27Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 22, 2026, ORTEX estimated 0.1% of free float sold short, 7.7 days to cover, cost to borrow 96.17%. Sign up for live short interest data.

Market Cap

132m USD | # 3215 in GB

Volume

22k shares | 840.42k USD

Shares Outstanding

93.7m

Free Float Shares

75.17% | 70.43m

Nasdaq:IPHA|
OTCPK:IPHY.F|
DB:IDD|
DB:IDDA|
XTRA:IDD|
ENXTPA:IPH

News

0EVI key data

Innate Pharma S.A. (LSE: 0EVI) has a market capitalization of $132.07M. Last close €1.27 (as of 2026-11-09); 52-week range €1.04 to €2.33. ORTEX data as of 2026-10-22: short interest was 0.13% of free float, 7.7 days to cover and the average cost to borrow was 96.17%. Sign up for live short interest data.

  • 0EVI news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.